The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1b/2, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who are naïve to anti-PD-1 therapy.
 
Antoni Ribas
Stock and Other Ownership Interests - Advaxis; Arcus Biosciences; Compugen; CytomX Therapeutics; Five Prime Therapeutics; FLX Bio; PACT Pharma; Tango Therapeutics
Consulting or Advisory Role - Amgen; Genentech/Roche; Merck; Novartis
 
Mohammed M. Milhem
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; EMD Serono; Genentech/Roche; Novartis
 
Christopher J. Hoimes
Honoraria - Seagen
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Foundation Medicine; Genentech/Roche; Prometheus; Seagen
Speakers' Bureau - Bristol-Myers Squibb; Genentech/Roche
Research Funding - Merck Sharp & Dohme
 
Asim Amin
Consulting or Advisory Role - Merck
Speakers' Bureau - Bristol-Myers Squibb; Merck; Pfizer
Research Funding - Bristol-Myers Squibb; Merck
 
Inderjit Mehmi
Speakers' Bureau - Bristol-Myers Squibb
 
Christopher D. Lao
Research Funding - Bristol-Myers Squibb; Merck; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Robert Martin Conry
Speakers' Bureau - Bristol-Myers Squibb; Merck; Novartis
 
Montaser F. Shaheen
No Relationships to Disclose
 
Sekwon Jang
No Relationships to Disclose
 
April K.S. Salama
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Abbvie (I); Bristol-Myers Squibb (Inst); Celldex (Inst); Dynavax Technologies (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Immunocore (Inst); Merck (Inst); Reata Pharmaceuticals (Inst)
 
Sanjeev Deva
No Relationships to Disclose
 
Theresa Michelle Medina
No Relationships to Disclose
 
Emmett V. Schmidt
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Abraham C.F. Leung
Employment - Dynavax Technologies; Merck
 
Biao Xing
Employment - Dynavax Technologies
 
Robert Janssen
Employment - Dynavax Technologies
Leadership - Dynavax Technologies
Stock and Other Ownership Interests - Dynavax Technologies; Merck
 
Georgina V. Long
Honoraria - Bristol-Myers Squibb; Incyte; Merck; Novartis; Roche
Consulting or Advisory Role - Amgen; Array BioPharma; Bristol-Myers Squibb; Incyte; MERCK; Novartis; Pierre Fabre; Roche/Genentech